Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Weinstein

Showing results (451-460 of 611) with videos related to

Pageof 62
Sort By:
Journal of Addiction Medicine|May 11, 2026
The Economic Impact of Medetomidine on Critical Care Utilization: A Longitudinal Analysis of Intensive Care Unit Charges for Opioid Withdrawal Across the Adulterated EraRobert Hilton, Shourjo Chakravorty, Mina Ghbrial, et al.
The New England Journal of Medicine|February 11, 2005
Expanded screening for HIV in the United States--an analysis of cost-effectivenessA David Paltiel, Milton C Weinstein, April D Kimmel, et al.
JAMA|February 19, 1997
The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatmentM G Hunink, L Goldman, A N Tosteson, et al.
Pharmacoeconomics|December 9, 2016
Cost-Effectiveness Analysis of Prophylaxis Treatment Strategies to Reduce the Incidence of Febrile Neutropenia in Patients with Early-Stage Breast Cancer or Non-Hodgkin LymphomaKelly Fust, Xiaoyan Li, Michael Maschio, et al.
Gynecologic Oncology|March 25, 2014
Cost-effectiveness of prophylaxis treatment strategies for febrile neutropenia in patients with recurrent ovarian cancerKelly Fust, Xiaoyan Li, Michael Maschio, et al.
Annals of Internal Medicine|March 20, 2001
Use of genotypic resistance testing to guide hiv therapy: clinical impact and cost-effectivenessM C Weinstein, S J Goldie, E Losina, et al.
Journal of Market Access & Health Policy|September 13, 2021
The impact of increasing multitarget stool DNA use among colorectal cancer screeners in a self-insured US employer populationJoanne M Hathway, Lesley-Ann Miller-Wilson, Abhishek Sharma, et al.
Circulation|May 1, 1992
Cost and health implications of cholesterol loweringL Goldman, D J Gordon, B M Rifkind, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 5, 1998
A Monte Carlo simulation of advanced HIV disease: application to prevention of CMV infectionA D Paltiel, J A Scharfstein, G R Seage, et al.
The Journal of Infectious Diseases|June 3, 2006
The survival benefits of AIDS treatment in the United StatesRochelle P Walensky, A David Paltiel, Elena Losina, et al.
Pageof 62

Showing results (451-460 of 611) with videos related to

Sort By:
Pageof 62
Journal of Addiction Medicine|May 11, 2026
The Economic Impact of Medetomidine on Critical Care Utilization: A Longitudinal Analysis of Intensive Care Unit Charges for Opioid Withdrawal Across the Adulterated EraRobert Hilton, Shourjo Chakravorty, Mina Ghbrial, et al.
The New England Journal of Medicine|February 11, 2005
Expanded screening for HIV in the United States--an analysis of cost-effectivenessA David Paltiel, Milton C Weinstein, April D Kimmel, et al.
JAMA|February 19, 1997
The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatmentM G Hunink, L Goldman, A N Tosteson, et al.
Pharmacoeconomics|December 9, 2016
Cost-Effectiveness Analysis of Prophylaxis Treatment Strategies to Reduce the Incidence of Febrile Neutropenia in Patients with Early-Stage Breast Cancer or Non-Hodgkin LymphomaKelly Fust, Xiaoyan Li, Michael Maschio, et al.
Gynecologic Oncology|March 25, 2014
Cost-effectiveness of prophylaxis treatment strategies for febrile neutropenia in patients with recurrent ovarian cancerKelly Fust, Xiaoyan Li, Michael Maschio, et al.
Annals of Internal Medicine|March 20, 2001
Use of genotypic resistance testing to guide hiv therapy: clinical impact and cost-effectivenessM C Weinstein, S J Goldie, E Losina, et al.
Journal of Market Access & Health Policy|September 13, 2021
The impact of increasing multitarget stool DNA use among colorectal cancer screeners in a self-insured US employer populationJoanne M Hathway, Lesley-Ann Miller-Wilson, Abhishek Sharma, et al.
Circulation|May 1, 1992
Cost and health implications of cholesterol loweringL Goldman, D J Gordon, B M Rifkind, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 5, 1998
A Monte Carlo simulation of advanced HIV disease: application to prevention of CMV infectionA D Paltiel, J A Scharfstein, G R Seage, et al.
The Journal of Infectious Diseases|June 3, 2006
The survival benefits of AIDS treatment in the United StatesRochelle P Walensky, A David Paltiel, Elena Losina, et al.
Pageof 62